表紙
市場調査レポート

クリプトスポリジウム症:世界の治験レビュー

Cryptosporidiosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 196106
出版日 ページ情報 英文 54 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
クリプトスポリジウム症:世界の治験レビュー Cryptosporidiosis Global Clinical Trials Review, H2, 2014
出版日: 2014年11月17日 ページ情報: 英文 54 Pages
概要

当レポートでは、クリプトスポリジウム症の治療薬に関する治験動向について、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報などをまとめてお届けします。

イントロダクション

地域別の治験動向

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 北米の主要国
    • 中東・アフリカの主要国

G7諸国における臨床試験

G7諸国における臨床試験:進捗状況別

相別の臨床試験

  • 進行中の治験:相別

臨床試験:進捗状況別

臨床試験:評価項目別

未完了の治験

期間ごとの被験者数

臨床試験:スポンサータイプ別

有力なスポンサー

  • クリプトスポリジウム症の治験に参加中の主要企業

有望な治療薬の比較

治験プロファイル

  • 主要企業の治験概要
    • Romark Laboratories, LC
    • Sanofi
    • Pfizer Inc
    • Johnson & Johnson
    • Univax Biologics Inc
    • Stolle Milk Biologics, Inc
    • Rhone-Poulenc Rorer (SA) (Pty) Ltd
    • AbbVie Inc 32
  • 主要大学/研究所/病院の治験概要
    • The National Institute of Allergy and Infectious Diseases
    • 名古屋大学大学院医学系研究科・医学部医学科
    • Cornell University
    • Tufts University

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2426CTIDB

GlobalData's clinical trial report, "Cryptosporidiosis Global Clinical Trials Review, H2, 2014" provides data on the Cryptosporidiosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptosporidiosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptosporidiosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cryptosporidiosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cryptosporidiosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cryptosporidiosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Romark Laboratories, L.C.
      • Clinical Trial Overview of Romark Laboratories, L.C.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Univax Biologics Inc
      • Clinical Trial Overview of Univax Biologics Inc
      • Stolle Milk Biologics, Inc.
      • Clinical Trial Overview of Stolle Milk Biologics, Inc.
      • Rhone-Poulenc Rorer (SA) (Pty) Ltd
      • Clinical Trial Overview of Rhone-Poulenc Rorer (SA) (Pty) Ltd
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Nagoya University Graduate School of Medicine
      • Clinical Trial Overview of Nagoya University Graduate School of Medicine
      • Cornell University
      • Clinical Trial Overview of Cornell University
      • Tufts University
      • Clinical Trial Overview of Tufts University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cryptosporidiosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Univax Biologics Inc, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stolle Milk Biologics, Inc., 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rhone-Poulenc Rorer (SA) (Pty) Ltd, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University Graduate School of Medicine, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014*

List of Figures

  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top